Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients

Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT), as one of the life-saving treatments for severe aplastic anemia (SAA), is widely used because of its great donor availability. Over decades, granulocyte colony-stimulating factor (G-CSF)/antithymocyte globulin (ATG)-based protocol...

Full description

Bibliographic Details
Main Authors: Xiaodi Ma, Zhengli Xu, Tingting Han, Yuanyuan Zhang, Wei Han, Haixia Fu, Xiaohui Zhang, Fan Lin, Xiaojun Huang, Lanping Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
post-transplant cyclophosphamide
GvHD prophylaxis
haploidentical hematopoietic stem cell transplant
severe aplastic anemia
bone marrow transplantation
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1173320/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1173320/full

Similar Items